All News

Patients with cystic fibrosis face a lifetime of time-consuming treatment. There are new breakthrough therapies that not only treat symptoms of the disease, but also the underlying causes, which represents a source of hope for patients. However, barriers to treatment still stand in the way, according to a new white paper from the Cystic Fibrosis Engagement Network.

US Senator Chuck Grassley (R-Iowa) asked why Medicaid did not move earlier to force Mylan to pay what it owed in rebates for the epinephrine injector.

Researchers from the United Kingdom combed studies to figure out which of several indicators, such as body mass index or waist circumference, were predictors of future cardiac events or health conditions, like hypertension or prediabetes.

Healthcare professionals working in the emergency department may be unaware of the costs of the care they deliver, according to a new study that asked clinicians to guess the cost of 3 hypothetical visits.

The National Heart, Lung, and Blood Institute has released the first-ever COPD National Action Plan, which is aimed at ending the illness.

The dangers of tobacco to users are well-known, but today the World Health Organization (WHO) is taking advantage of World No Tobacco Day to raise awareness of how tobacco impacts non-users, the environment, and society.

A new study finds that bariatric surgery can have beneficial effects for women beyond just weight loss: it was also associated with lower risk of female-specific cancers, like breast or ovarian cancer.

Patients with peripheral artery disease can now have supervised exercise therapy covered by Medicare, according to a recent announcement by CMS.

While regulators long ago saw enough cardiovascular safety data to approve insulin degludec, full trial results will be presented June 12 at the American Diabetes Association Scientific Sessions in San Diego.

Patients with metastatic non-small cell lung cancer (NSCLC) who have a rearrangement in the anaplastic lymphoma kinase (ALK) gene now have a first-line option: ceritinib.

Physicians' groups said in a letter they fear seniors will lose or forget to bring the new Medicare cards to appointments, and there is no backup plan for doctors to gain access to the new identification number.

Shortly after the FDA announced it would permit the sale of genetic tests to consumers, an editorial contends that these tests will actually contribute to the deluge of low-value, wasteful medical services that the healthcare system should try to eliminate.

The Center for Science in the Public Interest released the letter proactively after the Trump administration has already eased rules for school lunches and delayed implementation of a labeling rule for restaurants.

The findings are the results of a collaborative study conducted at various cancer institutions across the United States, which evaluated the impact of following the 2012 American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors.

A key step of seamless integration of technology across a healthcare system involves the payment function. Both internal-facing and consumer facing systems should be embedded in the workflow.

Although a report from the Surgeon General has determined that the aerosol vapor from e-cigarettes contains harmful chemicals like nicotine, a survey of US adults indicates that some are skeptical or unsure about the risk posed to children exposed to the vapor.

A new study in this week’s Morbidity and Mortality Weekly Report finds that people with arthritis are more likely to limit their activities due to their symptoms if they live in a rural county, indicating the need to offer targeted interventions to this population.

Congress still has to reauthorize the Prescription Drug User Fee Act, and it can have big consequences for rare disease patients if there is a delay.

Although providers might turn to PCSK9 inhibitors to treat patients at risk for atherosclerotic cardiovascular disease or familial hypercholesterolemia for whom statins do not work, the initial denial rate for this therapy can be very high.

This week, the top managed care news included the Congressional Budget Office's new score for the American Health Care Act; the White House released its fiscal year 2018 budget; and a cancer drug approval that is a first for the FDA.

Based on the results of the phase 2 ZUMA-1 trial in patients with refractory non-Hodgkin lymphoma, Kite Pharma has submitted for, and received, a priority review for its chimeric antigen receptor (CAR)-T cell treatment, axicabtagene ciloleucel.

A new study published in Diabetes Care investigates ways to prevent driving accidents among patients with type 1 diabetes, who may be at higher risk of having such mishaps.

Few people have adequate savings for long-term care, and most assume they will care for relatives and rely on family for their own care. A survey from the Associated Press and the NORC Center for Public Affairs Research found support for family leave policies across members of both parties.

A panel discussion on biosimilars at the ISPOR 22nd Annual International Meeting compared the progress in the United States with Europe, which has had a 10-year head start on the market.

Coverage of our peer-reviewed research in the healthcare and mainstream press.